NTPC earnings are projected to grow faster than Power Grid in the three years to FY27
The increase in competitive intensity may emerge as a headwind once again
Mobile number portability requests rose significantly in July 2024 indicating elevated churn in the telecom sector
The share of hybrid and firm and dispatchable tenders in renewable power projects rose from 10 percent in FY20 to 30 percent in FY24 and 46 percent in 5M FY25
The company can become one of India’s top renewable power generators if it achieves the stated targets
The healthcare company’s medium-term revenue growth visibility appears healthy
Aviation turbine fuel prices dropped to the lowest level in a year
Receivables of renewable energy project developers dropped as discoms began paying past bills
Medanta has strong capabilities to leverage its brand image and win the underserved and growing markets.
The share of non-fossil fuels in total electricity generation rose on strong growth in nuclear power and moderation in demand
KIMS is well-positioned to seize the growing demand for healthcare facilities in the country. Timely execution and ramp-up of new projects will be crucial
Profit margins of Sun Pharma, Dr Reddy’s Laboratories, Cipla and Zydus Lifesciences rose significantly from FY20 levels
CESC is scaling up green energy capacities. Adani Power, which once contemplated delisting, is aiming to double its electricity generation capacity base
The company is best placed to benefit from the synergies between paediatric and OB-GYN segments
The fund manager at InCred PMS decodes the puzzle of value investing in the fragmented pharma and healthcare space with key insights. He warns against the lure of quick profits, championing a long-term vision as the right path in the conquest of investment success in the sector.
Falling crop prices and low income are feared to weigh on farm investments in the US
Six of the top 10 companies by sales gained market share in the India pharma market in July 2024 on a moving annual turnover basis
With the ramp-up of new projects, the current revenue growth trajectory should continue into FY25-26
Apollo Hospitals, Fortis Healthcare and Max Healthcare clocked decent growth in revenues despite a disruption to international patient flows
With high-margin internet ticketing almost reaching saturation, incremental margin drivers may be absent
Though the stock offers value, the increase in competitive intensity is an area of concern
Traction in acute therapy drugs can help India pharma market to improve growth rate in FY25
The company has reduced prices for iron ore lumps and fines by 10 percent each
Demand environment across end-use segments remains a mixed bag
The company aims to gain leadership position in non-Suzlon wind energy OMS business